Suchergebnisse - "Le Malicot, Karine"

PubPharm (86)

1

First-Line LV5FU2 with or without Aflibercept in Patients with Non-Resectable Metastatic Colorectal Cancer : A Randomized Phase II Trial (PRODIGE 25-FFCD-FOLFA)

enthalten in: Cancers | 2024

von Legoux, J. | Faroux, R. | Barrière, N. | +14

2

FOLFIRI Plus Durvalumab With or Without Tremelimumab in Second-Line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma : The PRODIGE 59-FFCD 1707-DURIGAST Randomized Clinical Trial

enthalten in: JAMA oncology | 2024

von Tougeron, D. | Dahan, L. | Evesque, L. | +62

3

Management of non-metastatic anal cancer in the elderly : ancillary study of the French multicenter prospective cohort FFCD-ANABASE

enthalten in: British journal of cancer | 2024

von Gouriou, C. | Lemanski, C. | Pommier, P. | +17

4

Avelumab vs Standard Second-Line Chemotherapy in Patients With Metastatic Colorectal Cancer and Microsatellite Instability : A Randomized Clinical Trial

enthalten in: JAMA oncology | 2023

von Taïeb, J. | Bouche, O. | André, T. | +77

5

Panitumumab in combination with chemoradiotherapy for the treatment of locally-advanced anal canal carcinoma : Results of the FFCD 0904 phase II trial

enthalten in: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology | 2023

von Vendrely, V. | Ronchin, P. | Minsat, M. | +16

6

DCF versus doublet chemotherapy as first-line treatment of advanced squamous anal cell carcinoma : a multicenter propensity score-matching study

enthalten in: Experimental hematology & oncology | 2023

von Kim, S. | Vendrely, V. | Saint, A. | +20

7

DCF versus doublet chemotherapy as first-line treatment of advanced squamous anal cell carcinoma: a multicenter propensity score-matching study

enthalten in: Experimental hematology & oncology | 2023

von Kim, S. | Vendrely, V. | Saint, A. | +20

8

Carcinoembryonic antigen kinetics predict response to first-line treatment in metastatic colorectal cancer : Analysis from PRODIGE 9 trial

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2023

von Salfati, D. | Huot, M. | Aparicio, T. | +10

9

Treatment, outcome, and prognostic factors in non-metastatic anal cancer : The French nationwide cohort study FFCD-ANABASE

enthalten in: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology | 2023

von Vendrely, V. | Lemanski, C. | Pommier, P. | +22

10

Ipilimumab with atezolizumab-bevacizumab in patients with advanced hepatocellular carcinoma : The PRODIGE 81-FFCD 2101-TRIPLET-HCC trial

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2023

von Merle, P. | Blanc, J. | Edeline, J. | +15

1
2
3
4
5
6
7
8
9
Nächster »
[9]